Why Unilever plc & Reckitt Benckiser Group Plc Are Now Too Expensive For Me

Roland Head explains why he believes Unilever plc (LON:ULVR) and Reckitt Benckiser Group Plc (LON:RB) are now too expensive for new investors.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Consumer goods giants Unilever (LSE: ULVR) (NYSE: UL.US) and Reckitt Benckiser (LSE: RB) (NASDAQOTH: RBGLY.US) are regularly cited as examples of firms where you pay a premium for quality.

Until recently, I’ve agreed with this view: in recent years I’ve purchased shares in Unilever at around 2,000p and 2,400p, and have no intention of selling them.

However, shares in both companies have climbed by between 15% and 20% over the last 12 months, and I’ve reached my limit: I won’t buy either firm at today’s prices.

Why not?

Unilever and Reckitt don’t seem to be able to meet City expectations — consensus forecasts for Unilever’s 2015 earnings have fallen from 148p to 134p over the last twelve months, leaving the firm on a 2015 forecast P/E of almost 21.

That seems too high, to me, given that in its 2014 results, Unilever warned that market conditions were not expected to improve significantly in 2015.

It’s a similar story at Reckitt, which currently trades on a 2015 forecast P/E of 23 times and offers a prospective yield of just 2.4%.

In fairness, I think the problem might be that City forecasts are too optimistic: Unilever and Reckitt have been quite open about soft conditions emerging markets in their trading updates.

Changing shape

Neither company is standing still in the face of sub-par growth.

Reckitt demerged its pharmaceuticals business into a new London-listed firm, Indivior, earlier this year, in order to sharpen its focus on its core health and hygiene ranges.

Back in December, Unilever said it would move its slow-growing spreads and margarines business into a standalone unit, a move widely seen as a precursor to a sale of this business. This would enable Unilever to focus more heavily on personal care products where profit margins and sales growth are higher.

How much would I pay?

Unilever’s adjusted earnings per share have grown by an average of less than 5% since 2009, while the equivalent figure for Reckitt is 11%.

In my view, Unilever would be more reasonably valued on a P/E of 17, which would give a yield of about 4%, and a share price of around 2,300p.

Reckitt has delivered strong growth and enjoys higher operating profit margins than Unilever, but earnings are expected to fall this year. I’d be happy to pay around 4,500p for Reckitt, which would equate to a 2015 P/E of 18, and a prospective yield of around 2.9%.

Roland Head owns shares in Unilever. The Motley Fool UK owns shares of Unilever. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Chalkboard representation of risk versus reward on a pair of scales
Growth Shares

Why high oil prices could be good news for Lloyds shares

Jon Smith talks through the implications of elevated oil prices and translates that through to the potential impact on Lloyds'…

Read more »

Investing Articles

Lists of income stocks to buy almost never include this one — but with a forecast 8.2% yield, I think they should!

This FTSE firm, not always seen as an income play, has a forecast yield of 8.2%, underlining why it's one…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

Aviva’s share price is down 13% to under £7, despite outstanding 2025 results! Time for me to buy more?

I think Aviva’s share price reflects an outdated view of the business, and that gap between perception and reality is…

Read more »

Arrow symbol glowing amid black arrow symbols on black background.
Investing Articles

Shell’s £33+ share price is near an all-time high, so why am I going to buy more as soon as possible?

Shell's strong cash generation and improving growth drivers contrast with a share price well below my valuation, suggesting major long‑term…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

An 8.4% forecast yield but down 16%! Time for me to buy more of this FTSE 100 passive income star?

This FTSE 100 passive‑income machine is delivering rising payouts and strong forecasts, and its share price suggests the market hasn’t…

Read more »

CEO Mark Zuckerberg at F8 2019 event
Investing Articles

£10,000 invested in Meta Platforms Stock 5 years ago is now worth…

Meta Platforms has been throwing good money after bad at Reality Labs since 2021, but the stock has more than…

Read more »

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

£7,500 invested in Diageo shares 5 weeks ago is now worth…

Our writer wonders if Diageo shares are worth a look at a 14-year low, or whether this FTSE 100 spirits…

Read more »

National Grid engineers at a substation
Investing Articles

Is Warren Buffett’s firm about to buy this FTSE 100 company?

There’s always speculation about what Warren Buffett’s company might be doing. But one UK idea has a bit more to…

Read more »